MarketScreener Strategies Vertex Pharmaceuticals Incorporated
Stocks
VRTX
US92532F1003
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 529.59 USD | +0.29% |
|
+7.78% | +16.81% |
| 07-06 | Vertex Pharmaceuticals to Acquire Crinetics Pharmaceuticals for $10 Billion | DJ |
| 07-06 | Vertex to buy Crinetics for $10 billion to expand rare-disease business | RE |
MarketScreener Strategies
Search
| Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease | December 11, 2023 at 05:47 am | |
| Vertex Pharmaceuticals Incorporated : Confirms growth trajectory | May 04, 2023 at 09:35 am | |
![]() | Vertex Pharmaceuticals : A very promising pipeline | January 11, 2023 at 05:20 am |
No results match your criteria
- Stock Market
- Stocks
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions

















